Orphan diseases, also known as rare diseases, affect a small percentage of the population, often leading to challenges in diagnosis, treatment, and research due to limited financial incentives for pharmaceutical companies. These diseases can have significant impacts on patients and families, necessitating specialized healthcare approaches and advocacy for increased awareness and funding.